# Trial to Evaluate the Efficacy and Safety of R093877 in Patients With Chronic Idiopathic Constipation

> **NCT00596596** · PHASE2 · COMPLETED · sponsor: **Movetis** · enrollment: 313 (actual)

## Conditions studied

- Constipation

## Interventions

- **DRUG:** prucalopride
- **DRUG:** prucalopride
- **DRUG:** 2 mg prucalopride
- **DRUG:** 4 mg prucalopride
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00596596
- **Lead sponsor:** Movetis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-09
- **Primary completion:** 1997-06
- **Final completion:** 1997-06
- **Target enrollment:** 313 (ACTUAL)
- **Last updated:** 2008-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00596596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00596596, "Trial to Evaluate the Efficacy and Safety of R093877 in Patients With Chronic Idiopathic Constipation". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00596596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*